Skip to content

Clinical trials

Hodgkin Disease trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Country / region: Brazil Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20121
20141
20172
20181
20211
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Takeda3
Novartis Pharmaceuticals2
AstraZeneca1
Hospital Sao Rafael1
Instituto Nacional de Cancer, Brazil1
Universidade Federal do Rio de Janeiro1
University of Sao Paulo General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease13
Lymphoma, Non-Hodgkin3
Lymphoma2
Breast Neoplasms1
Cardiovascular Diseases1
Colonic Neoplasms1
Graft vs Host Disease1
Leukemia, Myeloid, Acute1
Lymphoma, T-Cell, Peripheral1
Myelodysplastic Syndromes1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.